HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Tetsuaki Arai Selected Research
Tetsuaki Arai Research Topics
Disease
44
Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
01/2022 - 12/2006
30
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
10/2020 - 07/2002
22
Alzheimer Disease (Alzheimer's Disease)
01/2023 - 05/2003
13
Frontotemporal Dementia (Semantic Dementia)
01/2022 - 05/2003
11
Cognitive Dysfunction
01/2023 - 01/2019
11
Dementia (Dementias)
01/2022 - 01/2004
11
TDP-43 Proteinopathies
10/2020 - 11/2008
9
Neurodegenerative Diseases (Neurodegenerative Disease)
01/2023 - 01/2006
6
Tauopathies
01/2022 - 01/2003
6
Sarcoma (Soft Tissue Sarcoma)
01/2022 - 01/2010
5
Atrophy
01/2021 - 07/2005
4
Corticobasal Degeneration
01/2022 - 05/2003
4
Synucleinopathies
01/2018 - 10/2007
3
Lewy Body Disease (Lewy Body Dementia)
01/2022 - 10/2007
3
Pick Disease of the Brain (Pick's Disease)
01/2022 - 05/2003
3
Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
09/2009 - 05/2003
3
Parkinsonian Disorders (Parkinsonism)
12/2008 - 01/2006
2
COVID-19
01/2022 - 01/2020
2
Major Depressive Disorder (Major Depressive Disorders)
01/2019 - 01/2018
2
Proteostasis Deficiencies
01/2017 - 11/2012
2
Amyloid Plaque
02/2011 - 01/2006
2
Diffuse Neurofibrillary Tangles with Calcification
02/2011 - 07/2005
2
Huntington Disease (Huntington's Disease)
09/2009 - 12/2008
2
Parkinson Disease (Parkinson's Disease)
09/2009 - 10/2006
2
Multiple System Atrophy
09/2009 - 10/2007
2
Neuroblastoma
10/2006 - 01/2006
1
Primary Progressive Aphasia
01/2023
1
Emotional Exhaustion
01/2022
1
Infections
01/2022
1
Schizophrenia (Dementia Praecox)
09/2021
1
Type 2 Diabetes Mellitus (MODY)
01/2021
1
Disorders of Excessive Somnolence (Hypersomnia)
01/2018
1
Snoring
01/2018
1
Disease Progression
02/2011
1
Delirium
02/2010
1
Diarrhea
02/2010
1
Progressive Multifocal Leukoencephalopathy
12/2009
1
Leukocytosis (Pleocytosis)
12/2008
1
Postmortem Changes (Adipocere)
08/2008
1
Motor Neuron Disease (Primary Lateral Sclerosis)
12/2006
Drug/Important Bio-Agent (IBA)
31
DNA-Binding Proteins (DNA Binding Protein)
IBA
01/2022 - 12/2006
26
Ubiquitin
IBA
11/2019 - 07/2002
19
Proteins (Proteins, Gene)
FDA Link
01/2022 - 01/2004
9
sarkosyl
IBA
01/2022 - 10/2007
8
Biomarkers (Surrogate Marker)
IBA
01/2023 - 07/2009
8
Antibodies
IBA
10/2010 - 01/2006
6
Amyloid (Amyloid Fibrils)
IBA
01/2022 - 01/2004
5
Tablets
IBA
01/2022 - 01/2019
5
Progranulins
IBA
02/2018 - 11/2008
4
Prions
IBA
01/2022 - 01/2012
4
Amyloid beta-Peptides
IBA
01/2022 - 01/2004
4
Synucleins
IBA
11/2019 - 12/2010
4
Microtubule-Associated Proteins (Microtubule-Associated Protein 2)
IBA
01/2010 - 05/2003
3
Protein Isoforms (Isoforms)
IBA
01/2022 - 11/2008
3
Granulins
IBA
02/2018 - 02/2015
2
DNA (Deoxyribonucleic Acid)
IBA
12/2014 - 12/2008
2
Methylene Blue (Methylthioninium Chloride)
FDA Link
01/2012 - 07/2009
2
4- N,N- dimethylamino- 1- naphthylisothiocyanate
IBA
02/2011 - 07/2005
2
Valosin Containing Protein
IBA
01/2010 - 11/2008
2
Heterogeneous-Nuclear Ribonucleoproteins (Informatin)
IBA
11/2009 - 10/2007
2
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
10/2006 - 01/2006
2
Messenger RNA (mRNA)
IBA
10/2006 - 01/2006
2
Thrombin
FDA Link
01/2006 - 02/2005
1
Indicators and Reagents (Reagents)
IBA
01/2023
1
4-amino-4'-hydroxylaminodiphenylsulfone (HADS)
IBA
01/2022
1
blonanserin
IBA
09/2021
1
Ataxin-2
IBA
10/2020
1
Diamond
IBA
01/2020
1
Rivastigmine (Exelon)
FDA Link
Generic
05/2019
1
Cholinesterase Inhibitors (Anticholinesterases)
IBA
05/2019
1
Iodine-123
IBA
11/2018
1
Protein Aggregates
IBA
01/2018
1
RNA (Ribonucleic Acid)
IBA
01/2018
1
Detergents (Detergent)
IBA
01/2018
1
Trypsin
IBA
02/2016
1
RNA Polymerase II (RNA Polymerase B)
IBA
08/2014
1
Presenilin-1
IBA
01/2014
1
p38 Mitogen-Activated Protein Kinases
IBA
03/2011
1
Cadherins (E-Cadherin)
IBA
03/2011
1
Superoxide Dismutase-1
IBA
01/2011
1
Peptide Hydrolases (Proteases)
FDA Link
11/2010
1
Thiamine (Aneurin)
FDA Link
02/2010
1
Green Fluorescent Proteins
IBA
09/2009
1
AD 5
IBA
09/2009
1
latrepirdine (dimebon)
IBA
07/2009
1
Acids
IBA
07/2009
1
Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)
IBA
01/2009
1
Coloring Agents (Dyes)
IBA
08/2008
1
Urea (Carbamide)
FDA Link
Generic
08/2008
1
Phosphopeptides
IBA
07/2008
1
alpha-Synuclein
IBA
10/2007
1
Casein Kinase II (Casein Kinase 2)
IBA
10/2007
1
Enzymes
IBA
10/2007
1
Phosphotransferases (Kinase)
IBA
10/2006
Therapy/Procedure
8
Therapeutics
01/2023 - 01/2010
2
Medical Day Care (Partial Hospitalization)
07/2022 - 01/2022
2
Transdermal Patch
09/2021 - 05/2019
1
Treatment Delay
01/2022
1
Home Nursing (Nursing, Home)
01/2022
1
Injections
04/2013